Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

NJEDA CCIT Pharmaceuticals Benefits from Variety of State Resources

6/6/2015

0 Comments

 
Trenton, NJ - Since arriving at the Commercialization Center for Innovative Technologies (CCIT) in North Brunswick  just over a year ago, Aucta Pharmaceuticals has built a name for itself within New Jersey’s life sciences community.  The company has already secured multiple sources of funding and its co-founder and Chief Executive Officer Dr. Shoufeng Li is highly regarded within the industry. The new drug product development company concentrates on novel and niche generic product development.  In addition, Aucta Pharmaceutical offers proprietary technology focusing on poor water soluble compounds, controlled release dosage forms and compliance enhancing formulations.
Aucta is the archetype of a New Jersey biotechnology company that has benefited from a variety of State resources.  As a CCIT tenant, it has access to affordable lab and office space in the heart of New Jersey’s Route 1 research and development corridor between Rutgers and Princeton universities.  Last June, the company participated in CCIT’s inaugural Founders and Funders event.  Held semi-annually at the life sciences incubator, Founders and Funders provides entrepreneurs and start-up companies with direct access to angel and venture capital investors.  In addition, Aucta has gained invaluable insight from CCIT’s Executives-in-Residence mentoring and advising program and from the other educational and networking events offered by the incubator.

The company has also taken advantage of New Jersey Angel Investor Tax Credit Program.  Since its inception in 2013, more than 200 investments have been made through the program, representing an infusion of more than $74 million into New Jersey companies.  The program provides tax credits of 10 percent of a qualified investment in an emerging New Jersey technology business that conducts research, manufacturing, or technology commercialization in the state. 

Given the breadth of State resources Aucta has tapped into to support its growth, Chief Executive Officer Dr. Shoufeng Li will be one of four panelists participating in the State’s “Partnering with New Jersey” discussion at the BIO International Convention in Philadelphia on June 16.  The panel will highlight the array of programs and resources available to help New Jersey technology and biotechnology companies start, grow, and thrive.  More information about the BIO International Convention can be found at 
http://convention.bio.org.

@NJEDATech spoke to Dr. Li about his experience growing his company in New Jersey and Aucta Pharmaceutical’s plans for the future:

What does funding provided through the Angel Investor Tax Credit mean to Aucta Pharmaceuticals?
As an early stage startup, funding from the Angel Investor Tax Credit program helps us to achieve critical business deliverables.  Early funding for startup companies is very difficult to get, and this program helps us to make that money work harder for us.

How has Aucta Pharmaceuticals benefited from locating its business at CCIT?
We have enjoyed the friendly help from EDA staff.  The Founders and Funders event was quite helpful for Aucta, as is the Executive-in-Residence program.  We love the opportunity the program provided for us to access a broad array of high quality talents.  The access and education on state wide funding opportunities are also quite useful.  

Why did you choose to grow your company in New Jersey?
I graduated from Rutgers with a PhD in Pharmaceutics in 1999.  I have been living in New Jersey for close to 20 years; New Jersey is my home so it was the natural choice for me to locate Aucta here in my home state.

What is Aucta Pharmaceutical’s biggest success to date?
In addition to partnering with pharmaceutical companies and raising VC funding, in a relatively short period of time, Aucta has developed itself into an R&D product development company with tangible assets. 

What’s in store for your company in the near future?
We are in discussion with a few generic and specialty pharmaceutical firms about our pipeline products and we are hoping to work together with them on some of these exciting opportunities.  We believe that these collaborations will be good for them, good for us, and good for the patients.

0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608-2002
609-858-9507